Superworth

TransMedics profit margin TMDX

Gross, operating and net profit as a share of revenue over the last twelve months, from 2022.

Net margin, 12 months
22.7%
Operating margin, 12 months
12.2%
Net margin on a year earlier
+9.2 pts
Peer median
8.2%

Over the twelve months to Jun 30, 2026, TransMedics kept 22.7% of its revenue as net profit, with an operating margin of 12.2% and a gross margin of 58.7%.

The median for 4 medical device stocks of a similar size is 8.2%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY202531.4%17.9%59.9%
FY20248.0%8.5%59.4%
FY2023−10.4%−11.9%63.8%
FY2022−38.8%−33.6%69.8%
FY2021n/an/a69.9%
FY2020n/an/a64.9%
FY2019n/an/a58.7%
FY2018n/an/a44.1%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY2622.7%+9.2 pts12.2%
Q1 FY2627.0%+17.0 pts14.9%
Q4 FY2531.4%+23.4 pts17.9%
Q3 FY2516.2%+8.1 pts16.9%
Q2 FY2513.5%+12.7 pts14.4%
Q1 FY2510.0%+13.5 pts10.8%
Q4 FY248.0%+18.4 pts8.5%
Q3 FY248.1%+26.8 pts7.8%
Q2 FY240.8%+12.6 pts−0.2%
Q1 FY24−3.4%+20.3 pts−4.8%
Q4 FY23−10.4%+28.4 pts−11.9%
Q3 FY23−18.7%+40.1 pts−19.9%

Against its peers

Companies in Medical - Devices nearest TransMedics' size, closest first, today.

CompanyProfit margin
TMDXTransMedics22.7%
CNMDCONMED4.1%
ITGRInteger7.0%
LIVNLivaNova12.8%
ZBHZimmer Biomet9.5%
Peer median8.2%

Where TransMedics ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on TransMedics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.